NCT04315025View on ClinicalTrials.gov

Safety Issues of Peribulbar Injection of UC-MSC in Patients With Retinitis Pigmentosa

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

October 7, 2018

Primary Completion Date

June 20, 2019

Study Completion Date

September 20, 2019

Conditions
Retinitis Pigmentosa
Interventions
BIOLOGICAL

Umbilical Cord Mesenchymal Stem Cell (UC-MSC)

Umbilical Cord Mesenchymal Stem Cell (UC-MSC) injected by peribulbar

BIOLOGICAL

Conditioned Medium (CM)

Conditioned Medium (CM) injected by peribulbar

Trial Locations (2)

55284

Sardjito Hospital, Yogyakarta

Unknown

Jakarta Eye Center Hospital, Jakarta

All Listed Sponsors
lead

PT. Prodia Stem Cell Indonesia

INDUSTRY

NCT04315025 - Safety Issues of Peribulbar Injection of UC-MSC in Patients With Retinitis Pigmentosa | Biotech Hunter | Biotech Hunter